Dr. Kristina Akopian, PSYD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 125 N Willow St Ste B, Kenai, AK 99611 Phone: 661-347-6524 |
Jacqueline Dawn Bock, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 215 Fidalgo Ave, Suite 104, Kenai, AK 99611 Phone: 907-335-4466 Fax: 907-335-4467 |
Dr. Mary M Bassir, PSYD Psychologist Medicare: Medicare Enrolled Practice Location: 508 Upland St, Kenai, AK 99611 Phone: 907-335-7500 |
Dr. Paul E Turner, PH.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 215 Fidalgo Ave Ste 102, Kenai, AK 99611 Phone: 907-283-7015 Fax: 907-283-3607 |
News Archive
Scientists of the Department of Personality, Evaluation and Psychological Treatment of the University of Granada have studied how some psychological variables such as erotophilia (positive attitude towards sexuality), sexual fantasies and anxiety are related to sexual desire in human beings.
Rare genetic diseases, long overlooked because they affect relatively few people, are getting new attention. Scientists at Washington University School of Medicine in St. Louis are reaching out to patient advocacy groups and offering to decode the DNA of 99 patients with rare diseases to help find the genetic alterations responsible for their illnesses.
As children's waistlines continue to grow, so have concerns about childhood obesity. According to a report released today by the University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health, childhood obesity is now the No. 1 health concern for kids in 2008, topping smoking and drug abuse. In 2007, childhood obesity ranked third among parents' top 10 overall health concerns for kids.
Lumosity, the leading brain training company, today announced a new web-based, big data methodology for conducting human cognitive performance research. Lumosity's research platform, the Human Cognition Project, contains the world's largest and continuously growing dataset of human cognitive performance, which currently includes more than 40 million people who have been tracked for up to 6 years.
Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the newly released U.S. Food and Drug Administration (FDA) guidance for the review and approval of biosimilars.
› Verified 7 days ago